Abstract
The thymus is a primary lymphoid organ where developing T cells (thymocytes) proliferate and differentiate before entering the systemic circulation to populate secondary lymphoid tissues and form the functional T cell repertoire. The thymus tightly controls the antigen specificity of these naive T cells in order to limit reaction with self antigens. In keeping with the importance of T cells to the health of the animal, their development and function are subject to many overlapping pathways and checkpoints. Therefore, many of the key players involved in T lymphocyte development, differentiation and function are potential targets for pharmaceutical intervention in aberrant T cell immune responses resulting in disease. This chapter outlines the complex function of the thymus, the range of changes seen as part of normal physiological and disease processes, and its response to immunotoxicants.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AIDz:
-
Autoimmune disease
- AIRE:
-
Autoimmune regulator gene
- APCs:
-
Antigen-presenting cells
- APS:
-
Autoimmune polyendocrinopathy syndrome
- CTL:
-
Cytotoxic T cells (CD8+)
- CTLA-4:
-
Cytotoxic T lymphocyte antigen
- DOCK8:
-
Dedicator of cytokinesis 8 protein
- ETPs:
-
Early thymic progenitor cells
- FOXP3:
-
Transcription factor forkhead box P3
- iTreg:
-
Induced regulatory T-cells
- Lck:
-
Lymphocyte-specific protein tyrosine kinase
- MHC:
-
Major histocompatibility complex
- nTreg:
-
Natural regulatory T cells (CD4+ CD25+ FOXP3+)
- PD-1:
-
Programmed death-1
- PSGL1:
-
P-selectin glycoprotein ligand 1
- Rag1 and Rag2:
-
Recombinase-activating genes 1 and 2
- Runx3:
-
Runt related transcription factor 3
- S1P:
-
Sphingosine 1-phosphate
- S1P1/S1PR1:
-
S1P receptor 1
- Syk:
-
Spleen tyrosine kinase
- T-bet:
-
T-box transcription factor
- TCR:
-
T cell receptor (CD3)
- TEC:
-
Thymic epithelial cells
- Th:
-
T helper cells (CD4+)
- Th0:
-
Naıve T-cells
- ThPOK:
-
Th-inducing BTB/POZ domain-containing Kruppel-like zinc-finger transcription factor
- TREG/Treg:
-
Regulatory T cell
- ZAP-70:
-
Zeta chain associated protein-70
References
Agmon-Levin N et al (2011) Explosion of autoimmune diseases and the mosaic of old and novel factors. Cell Mol Immunol 8:189–192
Ahmed S et al (1985) Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 121:531–551
Allan R, Nutt S (2014) Deciphering the epigenetic code of T lymphocytes. Immunol Rev 261:50–61
Anderson G et al (1996) Cellular interactions in thymocyte development. Annu Rev Immunol 14:73–99
Anderson M et al (2005) The cellular mechanism of aire control of T cell tolerance. Immunity 23:227–239
Aspinall R (2000) Longevity and the immune response. Biogerontology 1:273–78
Barrett J et al (2009) Cancer chemotherapy and immune regulation. Am J Immunol 5(1):8–16
Bernard C et al (2016) Thymoma associated with autoimmune diseases: 85 cases and literature review. Autoimmun Rev 15(2016):82–92
Bernardi A et al (2015) Selective estrogen receptor modulators in T cell development and T cell dependent inflammation. Immunobiology. doi:10.1016/j.imbio.2015.05.009
Berzins S et al (1998) The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool. J Exp Med 187:1839–1848
Blazer B et al (2012) Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 12:443–458
Boehm T, Swann J (2013) Thymus involution and regeneration: two sides of the same coin? Nat Rev Immunol 13:831–838
Bolon B (2012) Cellular and molecular mechanisms of autoimmune disease. Toxicol Pathol 40:216–229
Bradley A et al (2012) Incidences and range of spontaneous findings in the lymphoid and haemopoietic system of control Charles River CD-1 Mice (Crl: CD-1(ICR) BR) used in chronic toxicity studies. Toxicol Pathol 40:375–381
Brandes K et al (2004) Comparative morphologic and immunohistochemical investigation of spontaneously occurring thymomas in a colony of European hamsters. Vet Pathol 41:346–352
Brelinska R, Warchol J (1997) Thymic nurse cells: their functional ultrastructure. Microsc Res Tech 38(3):250–266
Brinkmann V et al (2010) Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov 9:883–897
Bruijntjes J et al (1993) Epithelium-free area in the thymic cortex of rats. Dev Immunol 3:113–122
Buckley R (2002) Primary cellular immunodeficiencies. J Allergy Clin Immunol 109:747–757
Bunting M et al (2011) Finding their niche: chemokines directing cell migration in the thymus. Immunol Cell Biol 89:185–196
Burns-Naas LA et al (2001) Toxic responses of the immune system. In: Klaassen C (ed) Casarett and Doull’s Toxicology. The basic science of poisons, 6th edn. Mc Graw-Hill, New York, pp 419–470
Buters J et al (1999) Cytochrome P450 CYP1B1 determines susceptibility to 7, 12 dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci USA 96:1977–82
Cheroutre H et al (2013) CD4 CTL: living up to the challenge. Semin Immunol 25:273–281
Clark L et al (1999) Cellular and molecular characterization of the Scurfy mouse mutant. J Immunol 162:2546–2554
Corman L (1985) Effects of specific nutrients on the immune response. Selected clinical applications. Med Clin North Am 69:759–91
Crivellato E et al (2004) Setting the stage: an anatomist’s view of the immune system. Trends Immunol 25(4):210–217
Cyster J (2009) Settling the thymus: immigration requirements. J Exp Med 206:731–734
De Waal E et al (1997) Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin, bis(tri-n-butyltin) oxide and cyclosporine on thymus histophysiology. Crit Rev Toxicol 27:381–430
Douek D, Altmann D (2000) T-cell apoptosis and differential human leucocyte antigen class II expression in human thymus. Immunology 99:249–256
Dominguez-Gerpe L, Rey-Mendez M (2001) Alterations induced by chronic stress in lymphocyte subsets of blood and primary and secondary immune organs of mice. BMC Immunol 2:7
Dominguez-gerpe L (2003) Evolution of the thymus size in response to physiological and random events throughout life. Microsc Res Tech 62:464–476
Dunnick J et al (1997) Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient (+/−) mice. Toxicol Pathol 25(6):533–40
Egwuagu C (2009) STAT3 in CD4+ T helper cell differentiation and inflammatory diseases. Cytokine 47(3):149–156
Elmore S (2006) Enhanced histopathology evaluation of thymus. Toxicol Pathol 34:656–665
Ercolini A, Miller S (2009) The role of infections in autoimmune disease. Clin Exp Immunol 155:1–15
Ermann J, Fathman G (2001) Autoimmune diseases: genes, bugs and failed regulation. Nat Immunol 2:759–761
Everds N et al (2013) Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment. Toxicol Pathol 41:560–614
Fife B, Pauken K (2011) The role of the PD-1 pathway in autoimmunity and peripheral tolerance Ann NY Acad Sci. 1217:45–59
Fontenot J, Rudensky A (2005) A well adapted regulatory contrivance:regulatory T cell development and the forkhead family transcription factor Foxp3. Nature Immunology (6):331–337
Foreman O et al (2011) Opportunistic bacterial infections in breeding colonies of the NSG mouse strain. Vet Pathol 48(2):495–499
Francisco L et al (2010) The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 236:219–242
Frith C et al (1985) A color atlas of hematopoietic pathology of mice. Toxicology Pathology Associates, Little Rock, AR, pp 5–13
Frith C et al (2001) Hematopoietic system. In: Mohr U (ed) International Classification of Rodent Tumors the mouse, 1st edn. Springer, Heidelberg, pp 432–451
Greaves P (2012) Hematopoietic and lymphatic systems, Histopathology of preclinical toxicity studies. Elsevier Academic, Amsterdam, pp 99–155
Griem P et al (1998) Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 19:133–41
Gribble E et al (2007) Toxicity as a result of immunostimulation by biologics. Expert Opin Drug Metab Toxicol 3(2):209–234
Good R, Lorenz E (1992) Nutrition and cellular immunity. lnt J lmmunopharmacol 14(3):361–366
Gopinath C (1996) Pathology of toxic effects on the immune system. Inflam Res 45:S74–S78
Gossens K et al (2009) Thymic progenitor homing and lymphocyte homeostasis are linked via S1P-controlled expression of thymic P-selectin/CCL25. J Exp Med 206:761–778
Haley P (2003) Species differences in the structure and function of the immune system. Toxicology 188:49–71
Haley P (2013) Lymphoid system. In: Sahota P, Popp J, Hardisty J, Gopinath C (eds) Toxicologic pathology. Non clinical safety assessment, 1st edn. CRC, Boca Raton, FL, pp 517–560
Haley P et al (2005) STP position paper: best practice guideline for the routine pathology evaluation of the immune system. Toxicol Pathol 33:404–407
Hansen C (1978) The nude gene and its effects. In: Fogh J, Giovanella B (eds) The nude mouse in experimental and clinical research, 1st edn. Academic, New York, pp 1–12
Harrison M et al (2014) A CRISPR view of development. Genes Dev 28:1859–1872
Henden A, Hill G (2015) Cytokines in graft-versus-host disease. J Immunol 194:4604–4612
Herold M et al (2006) Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 63:60–72
Hirokawa K et al (1984) Differential rate of age-related decline in immune functions in genetically defined mice with different tumour incidence and lifespan. Gerontology 30:223–233
Holladay S (1999) Prenatal immunotoxicant exposure and postnatal autoimmune disease. Environ Health Perspect 107(Suppl 5):687–91
Hsu P et al (2014) Development and applications of CRISPR-Cas9 for genome editing. Cell 157:1262–1278
Murphy K (Ed) (2012) Janeway’s immunobiology, 8th edn. Garland Science, Taylor and Francis Group, London and New York
Jain N et al (2010) Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity. Proc Natl Acad Sci USA 107:1524–528
Kendal M, Clarke A (2000) The thymus in the mouse changes its activity during pregnancy: a study of the microenvironment. J Anat 197(3):393–411
Koller L (1987) Immunotoxicology today. Toxicol Pathol 15:346–51
Owen J, Punt J, Stranford S (ed) (2013) Kuby immunology, 7th edn. W H Freeman, New York
Lee I et al (1995) Presence of eosinophilic precursors in the human thymus: Evidence for intra-thymic differentiation of cells in eosinophilic lineage. Pathol Int 45:655–662
Matloubian M et al (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427:355–360
Meda F et al (2011) The epigenetics of autoimmunity. Cell Mol Immunol 8:226–236
Melnick R, Sills R (2001) Comparative carcinogenicity of 1,3- butadiene, isoprene, and chloroprene in rats and mice. Chem Biol Interact 135–136:27–42
Meriggioli M, Sanders D (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8(5):475–490
Michels A, Gottlieb P (2010) Autoimmune polyglandular syndromes. Nat Rev Endocrinol 6:270–277
Miller J (2011) The golden anniversary of the thymus. Nat Rev Immunol 11:489–495
Miller S, Weinmann A (2010) Molecular mechanisms by which T-bet regulates T-helper cell commitment. Immunol Rev 238(1):233–246
Mittal A et al (1988) Involution of thymic epithelium and low serum thymulin bioactivity in weanling mice subjected to severe food intake restriction or severe protein deficiency. Exp Mol Pathol 48:226–235
Morton D et al (2008) N-Methyl-N-Nitrosourea (MNU): a positive control chemical for p53+/− mouse carcinogenicity studies. Toxicol Pathol 36:926–931
Mucida D et al (2013) Transcriptional reprogramming of mature CD4+ helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes. Nat Immunol 14:281–289
Münz C et al (2009) Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 9:246–258
Naito T et al (2011) Transcriptional control of T-cell development. Int Immunol 23(11):661–668
Nitta T et al (2008) Thymic microenvironments for T-cell repertoire formation. Adv Immunol 99:60–94
Nguyen L, Ohashi P (2015) Clinical blockade of PD1 and LAG3- potential mechanisms of action. Nat Rev Immunol 15:45–56
Nonoyama S et al (1993) Strain-dependent leakiness of mice with severe combined immune deficiency. J Immunol 150(9):3817–3824
Notarangelo L (2014) Combined immunodeficiencies with nonfunctional T lymphocytes. Adv Immunol 121:121–190
Ochs H et al (2002) Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome and the Scurfy mutant mouse. Immunol Allergy Clin North Am 22:357–68
Ohaegbulam K et al (2015) Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Trends Mol Med 21:24–33
Pardoll D (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12:252–264
Parker G et al (2015) Histological Features of Postnatal Development of Immune System Organs in the Sprague-Dawley Rat Toxicol Pathol 43(6):794–815
Pearse G (2006) Histopathology of the thymus. Toxicol Pathol 34:515–547
Pearse G et al (2009) Time-course study of the immunotoxic effects of the anticancer drug chlorambucil in the rat. Toxicol Pathol 37:887–901
Perryman L (2004) Molecular pathology of severe combined immunodeficiency in mice, horses, and dogs. Vet Pathol 2:95–100
Peterson R (2012) Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression. Toxicol Pathol 40:186–204
Plecas-Solarovic B et al (2006) Morphometrical characteristics of age-associated changes in the thymus of old male Wistar rats. Anat Histol Embryol 35:380–386
Ploeman J-P et al (2003) The incidence of thymic B lymphoid follicles in healthy beagle dogs. Toxicol Pathol 31(2):214–219
Preziosi R et al (1995) Quantitative determination of thymic eosinophilia in swine. Ital J Anat Embryol 100(3):171–178
Rao T, Richardson B (1999) Environmentally induced autoimmune diseases: potential mechanisms. Environ Health Perspect 107(Suppl 5):737–42
Reindel J et al (2001) Systemic proliferative changes and clinical signs in cynomolgus monkeys administered a recombinant derivative of human epidermal growth factor. Toxicol Pathol 29(2):159–173
Reis B et al (2013) Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4+ T cellimmunity. Nat Immunol 14:271–80
Rezzani R (2004) Cyclosporine A and adverse effects on organs: histochemical studies. Prog Histochem Cytochem 39:85–128
Robson L, Schwarz M (1975) Vitamin B6 deficiency and the lymphoid system. II. Effects of vitamin B6 deficiency in utero on the immunological competence of the offspring. Cell Immunol 16:145–62
Rogner U, Avner P (2003) Congenic mice: cutting tools for complex immune disorders. Nat Rev Immunol 3:243–252
Rosai J, Levine G (1976) Tumors of the thymus. Armed Forces Institute of Pathology, vol 2, Fasc 13. Washington, DC, pp 34–37
Rosenberg H (2013) Eosinophils: changing perspectives in health and disease. Nat Rev Immunol 13:9–22
Rothenberg E, Taghon T (2005) Molecular genetics of T cell development. Annu Rev Immunol 23:601–49
Sakaguchi S (2005) Naturally arising FOXP3-expressing CD25 + CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6(4):345–52
Samarkos M, Vaiopoulos G (2005) The role of infections in the pathogenesis of autoimmune diseases. Curr Drug Targets Inflamm Allergy 4:71–75
Sano S et al (2001) Stat 3 in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocytes survival. Immunity 15:261–273
Sayegh M et al (1998) The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 338:1813–1821
Schiffenbauer J et al (1998) The possible role of bacterial superantigens in the pathogenesis of autoimmune disorders. Immunol Today 19:117–20
Schwartz R (2003) T cell anergy. Annu Rev Immunol 21:305–34
Schuurman H et al (1994) Histopathology of the immune system as a tool to assess immunotoxicity. Toxicology 86:187–212
Seymour R et al (2006) Abnormal lymphoid organ development in immunodeficient mutant mice. Vet Pathol 43:401–423
Shahar S et al (2011) Thymoma and autoimmunity. Cell Mol Immunol 8:199–202
Shultz LD et al (2005) Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R ϒnull mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174:6477–6489
Shultz LD et al (2012) Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol 12:786–798
Smith D, Germolec D (1999) Introduction to immunology and autoimmunity. Environ Health Perspect 107(Suppl 5):661–65
Smith S, Ossa-Gomez L (1981) A quantitative histologic comparison of the thymus in 100 healthy and diseased adults. Am J Clin Pathol 76:657–65
Snyder P (2012) Immunology for the toxicologic pathologist. Toxicol Pathol 40:143–147
Spiegel S, Milstien S (2011) The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol 11:403–415
Spoor M et al (2008) Characterisation of age and gender related changes in the spleen and thymus from control cynomologous macaques used in toxicity studies. Toxicol Pathol 36:695–704
Stefanski S et al (1990) Spleen, lymph node and thymus. In: Boorman G, Eustis S, Elwell M, Montgomery C, MacKenzie W (eds) Pathology of the Fischer rat, 1st edn. Academic, San Diego, CA, pp 316–393
Suster S, Rosai J (1992) Thymus. In: Sternberg S (ed) Histology for pathologists, 1st edn. Raven, New York, pp 261–275
Szymanska H et al (2014) Neoplastic and nonneoplastic lesions in aging mice of unique and common inbred strains contribution to modeling of human neoplastic diseases. Vet Pathol 51(3):663–679
Takahama Y (2006) Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol 6:127–135
Taub D et al (2005) Insights into thymic ageing and regeneration. Immunol Rev 205:72–93
Thomson A et al (2009) Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol 9:324–337
Throsby M et al (2000) CD11c + eosinophils in the murine thymus: developmental regulation and recruitment upon Class 1 MHC-restricted thymocyte depletion. J Immunol 165:1965–1975
van Ewijk W et al (1988) Lymphoid microenvironments in the thymus and lymph node. Scanning Microsc 2(4):2129–2140
van Ewijk W et al (1994) Crosstalk in mouse thymus. Immunol Today 15:214–217
Venkataraman K et al (2008) Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 102:669–676
Waldron-Lynch F, Herold M (2011) Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes. Nat Rev Drug Discov 10:439–452
Ward J et al (1999) Thymus spleen and lymph nodes. In: Maronpot R (ed) Pathology of the mouse, 1st edn. Cache River, Vienna IL, pp 333–360
Ward J (2006) Lymphomas and leukemias in mice. Exp Toxicol Pathol 57:377–381
Ward J et al (2012) Differentiation of rodent immune and hematopoietic system reactive lesions from neoplasias. Toxicol Pathol 40:425–434
Watanabe N et al (2005) Hassall’s corpuscles instruct dendritic cells to induce CD4 + CD25+ regulatory T cells in human thymus. Nature 436(7054):1181–1185
Weaver J (2012) Establishing the carcinogenic risk of immunomodulatory drugs. Toxicol Pathol 40:267–271
Wei S et al (2005) Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat Immunol 6:1228–1235
Wilde B et al (2010) T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells? Arthritis Res Ther 12:204
Willcox N et al (2008) Autoimmunizing mechanisms in thymoma and thymus. Ann N Y Acad Sci 1132:163–73
Williams K et al (2007) T cell immune reconstitution following lymphodepletion. Semin Immunol 19:318–330
Woodbine L et al (2013) PRKDC mutations in a SCID patient with profound neurological abnormalities. J Clin Invest 123(7):2969–2980
Zisimopoulou P et al (2013) Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens. Autoimmun Rev 12:924–30
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Pearse, G. (2017). Thymus. In: Parker, G. (eds) Immunopathology in Toxicology and Drug Development. Molecular and Integrative Toxicology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-47385-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-47385-7_1
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-47384-0
Online ISBN: 978-3-319-47385-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)